Adoption of Direct-to-Consumer Laboratory Testing amid Covid-19 Pandemic
The Europe direct-to-consumer laboratory testing market witnessed an increasing demand due to consumer awareness in European countries. The increasing prevalence of infectious diseases post-pandemic is also driving the growth of the Europe direct-to-consumer laboratory testing market. Advancements in healthcare and adoption of direct-to-consumer laboratory testing methods are due to the rapidly spreading coronavirus in the European countries. Companies in the Europe direct-to-consumer laboratory testing market are focused on providing their services to cater to the increasing demand for consumer-driven laboratory testing procedures. These companies are striving to grab lucrative revenue opportunities by conducting rapid testing outside clinics and hospitals. Market players are entering into mergers & agreements with contract manufacturers to develop necessary testing kits that can be directly used by consumers.
Popularity Due to Increasing Consumer Awareness in European Countries
The Europe direct-to-consumer laboratory testing market is expected to surpass US$ 7.8 Bn by 2031. In countries such as Spain, Germany, France, and Italy, consumers are more aware of the advantages of direct-to-consumer laboratory tests over conventional laboratory testing methods. Increasing demand for disease risk assessment tests, COVID-19 tests, pregnancy tests, and various other nutrigenetics tests are boosting the Europe direct-to-consumer laboratory testing market. Governments are investing in promoting awareness and importance of such testing methods to cater to the increasing demand from consumers. The rising presence of companies and market players to provide these convenience services also fuels the Europe direct-to-consumer laboratory testing market.
Increasing Geriatric Population and Growing Prevalence of Infectious Diseases
With changing lifestyles and increasing prevalence of infectious diseases such as coronavirus, HIV, Influenza, etc., there is a continuous demand for rapid diagnosis and treatment. The rise in the number of lifestyle diseases such as diabetes, heart diseases, obesity, hypertension, cancer, etc. has augmented the demand for convenient diagnostic tests. Rapid test procedures, availability of test kits, and accurate results can prevent the spreading of such diseases. People are adopting innovative healthcare practices with rapid advancements in technologies. The increasing geriatric population in Europe is responsible for the increasing demand for convenient direct-to-consumer laboratory tests (DTC), which, in turn, boost the Europe direct-to-consumer laboratory testing market growth. Ongoing research & development in the direct-to-consumer procedures to perform variety of tests is likely to drive market in Europe.
Rapid Advancements in Healthcare, Test Confidentiality, and Convenience
Due to rapid advancements in the healthcare industry, acceptance of telehealth practices, and digitalization, people are becoming smarter to take advantage of recent trends and technologies that are being used in healthcare. Direct-to-consumer laboratory tests allow consumers to save their time and efforts to visit medical professionals for disease diagnosis. Direct-to-consumer laboratory tests can be ordered online from laboratory and test results are used to monitor health condition and to find out unknown medical disorders. This is the efficient way to involve consumer in the clinical diagnosis process; hence, they are called consumer-focused. The increasing popularity of such tests is due to its confidentiality and convenience where consumer need not have to wait for test results and tiring procedure to meet healthcare professionals. This factor contributes to the growth of the Europe direct-to-consumer laboratory testing market.
Analysts’ Viewpoint
Increased awareness and genetic research & development activities initiated by various countries are driving the market in the region. The acceptance of modern technological practices introduced in the healthcare industry for the betterment of patients is also contributing to the Europe direct-to-consumer laboratory testing market growth. Consumer-driven testing is widely popular in European countries, due to its increased awareness, convenience, and accurate diagnosis of various health conditions. Increasing efforts of companies operating in the Europe direct-to-consumer laboratory testing market boost the demand for personalized healthcare services on a timely basis, where consumers can order test kits online and laboratory professionals delivers test results directly to the consumers without the involvement of health practitioners.
Europe Direct-to-Consumer Laboratory Testing Market: Overview
Europe Direct-to-Consumer Laboratory Testing Market: Key Segments
Europe Direct-to-Consumer Laboratory Testing Market: Regional Outlook
Companies Covered in Europe Direct-to-Consumer Laboratory Testing Market Report
Europe Direct-to-Consumer Laboratory Testing Market Snapshot
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 603 Mn |
|
Market Forecast Value in 2031 |
US$ 7.8 Bn |
|
Growth Rate (CAGR) |
26% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis at Europe as well as country level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key industry events, etc. |
|
Competition Landscape |
Market share analysis by company (2020) |
|
Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc. |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Regions Covered |
Europe |
|
Germany |
|
|
U.K. |
|
|
France |
|
|
Italy |
|
|
Spain |
|
|
Rest of Europe |
|
|
Companies Profiled |
23andMe, Inc. |
|
Ancestry |
|
|
CircleDNA |
|
|
Eurofins Scientific |
|
|
Family Tree DNA (Gene by Gene) |
|
|
Laboratory Corporation of America Holdings |
|
|
Living DNA Ltd. |
|
|
Medichecks.com Ltd. |
|
|
MyHeritage Ltd. |
|
|
MyMedLab, Inc. |
|
|
Quest Diagnostics Incorporated |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Europe direct-to-consumer laboratory testing market is expected to surpass US$ 7.8 Bn by 2031
Europe direct-to-consumer laboratory testing market is driven by increasing geriatric population and growing prevalence of infectious diseases
Europe direct-to-consumer laboratory testing market is driven by increasing geriatric population and growing prevalence of infectious diseases
The diagnostic centers segment dominated the direct-to-consumer laboratory testing market in Europe during the forecast period.
Key players in the direct-to-consumer laboratory testing market include 23andMe, Inc., Ancestry, CircleDNA, Eurofins Scientific, Family Tree DNA (Gene by Gene)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Europe Direct-to-Consumer Laboratory Testing Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)
5.2. Disease Prevalence & Incidence Rate
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017–2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type
7. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017–2031
7.3.1. Genetic Testing
7.3.1.1. Nutrigenetics Test
7.3.1.1.1. Weight Control
7.3.1.1.2. Lactose Intolerance
7.3.1.1.3. Others
7.3.1.2. Celiac Disease Test
7.3.1.3. Sports & Physical Activity Testing
7.3.1.4. Men's Health Tests
7.3.1.5. Women's Health Tests
7.3.1.6. Pregnancy & Prenatal Screening Test
7.3.1.7. General Health Testing
7.3.1.8. Others
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Sexual Health Tests
7.3.2.1.1. HIV
7.3.2.1.2. Chlamydia
7.3.2.1.3. Others
7.3.2.2. Cancer Predisposition Tests
7.3.2.3. Others
7.3.3. CBC
7.3.4. Chronic Disease Testing
7.3.4.1. Diabetes Testing
7.3.4.2. Hypertension
7.3.4.3. Others
7.3.5. COVID-19 Testing
7.3.6. TSH Testing
7.3.7. Others
7.4. Market Attractiveness Analysis, by Test Type
8. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Provider, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Speciality Labs
8.3.4. Diagnostic Centres
8.4. Market Attractiveness Analysis, by Provider
9. Germany Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Sample Type, 2017–2031
9.2.1. Blood
9.2.2. Urine
9.2.3. Saliva
9.2.4. Others
9.3. Market Value Forecast, by Test Type, 2017–2031
9.3.1. Genetic Testing
9.3.1.1. Nutrigenetics Test
9.3.1.1.1. Weight Control
9.3.1.1.2. Lactose Intolerance
9.3.1.1.3. Others
9.3.1.2. Celiac Disease Test
9.3.1.3. Sports & Physical Activity Testing
9.3.1.4. Men's Health Tests
9.3.1.5. Women's Health Tests
9.3.1.6. Pregnancy & Prenatal Screening Test
9.3.1.7. General Health Testing
9.3.1.8. Others
9.3.2. Disease Risk Assessment Testing
9.3.2.1. Sexual Health Tests
9.3.2.1.1. HIV
9.3.2.1.2. Chlamydia
9.3.2.1.3. Others
9.3.2.2. Cancer Predisposition Tests
9.3.2.3. Others
9.3.3. CBC
9.3.4. Chronic Disease Testing
9.3.4.1. Diabetes Testing
9.3.4.2. Hypertension
9.3.4.3. Others
9.3.5. COVID-19 Testing
9.3.6. TSH Testing
9.3.7. Others
9.4. Market Value Forecast, by Provider, 2017–2031
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Speciality Labs
9.4.4. Diagnostic Centres
10. U.K. Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Sample Type, 2017–2031
10.2.1. Blood
10.2.2. Urine
10.2.3. Saliva
10.2.4. Others
10.3. Market Value Forecast, by Test Type, 2017–2031
10.3.1. Genetic Testing
10.3.1.1. Nutrigenetics Test
10.3.1.1.1. Weight Control
10.3.1.1.2. Lactose Intolerance
10.3.1.1.3. Others
10.3.1.2. Celiac Disease Test
10.3.1.3. Sports & Physical Activity Testing
10.3.1.4. Men's Health Tests
10.3.1.5. Women's Health Tests
10.3.1.6. Pregnancy & Prenatal Screening Test
10.3.1.7. General Health Testing
10.3.1.8. Others
10.3.2. Disease Risk Assessment Testing
10.3.2.1. Sexual Health Tests
10.3.2.1.1. HIV
10.3.2.1.2. Chlamydia
10.3.2.1.3. Others
10.3.2.2. Cancer Predisposition Tests
10.3.2.3. Others
10.3.2.4. CBC
10.3.2.5. Chronic Disease Testing
10.3.2.5.1. Diabetes Testing
10.3.2.5.2. Hypertension
10.3.2.5.3. Others
10.3.2.6. COVID-110 Testing
10.3.2.7. TSH Testing
10.3.2.8. Others
10.4. Market Value Forecast, by Provider, 2017–2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Speciality Labs
10.4.4. Diagnostic Centres
11. France Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Sample Type, 2017–2031
11.2.1. Blood
11.2.2. Urine
11.2.3. Saliva
11.2.4. Others
11.3. Market Value Forecast, by Test Type, 2017–2031
11.3.1. Genetic Testing
11.3.1.1. Nutrigenetics Test
11.3.1.1.1. Weight Control
11.3.1.1.2. Lactose Intolerance
11.3.1.1.3. Others
11.3.1.2. Celiac Disease Test
11.3.1.3. Sports & Physical Activity Testing
11.3.1.4. Men's Health Tests
11.3.1.5. Women's Health Tests
11.3.1.6. Pregnancy & Prenatal Screening Test
11.3.1.7. General Health Testing
11.3.1.8. Others
11.3.2. Disease Risk Assessment Testing
11.3.2.1. Sexual Health Tests
11.3.2.1.1. HIV
11.3.2.1.2. Chlamydia
11.3.2.1.3. Others
11.3.2.2. Cancer Predisposition Tests
11.3.2.3. Others
11.3.3. CBC
11.3.4. Chronic Disease Testing
11.3.4.1. Diabetes Testing
11.3.4.2. Hypertension
11.3.4.3. Others
11.3.5. COVID-19 Testing
11.3.6. TSH Testing
11.3.7. Others
11.4. Market Value Forecast, by Provider, 2017–2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Speciality Labs
11.4.4. Diagnostic Centres
12. Italy Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Sample Type, 2017–2031
12.2.1. Blood
12.2.2. Urine
12.2.3. Saliva
12.2.4. Others
12.3. Market Value Forecast, by Test Type, 2017–2031
12.3.1. Genetic Testing
12.3.1.1. Nutrigenetics Test
12.3.1.1.1. Weight Control
12.3.1.1.2. Lactose Intolerance
12.3.1.1.3. Others
12.3.1.2. Celiac Disease Test
12.3.1.3. Sports & Physical Activity Testing
12.3.1.4. Men's Health Tests
12.3.1.5. Women's Health Tests
12.3.1.6. Pregnancy & Prenatal Screening Test
12.3.1.7. General Health Testing
12.3.1.8. Others
12.3.2. Disease Risk Assessment Testing
12.3.2.1. Sexual Health Tests
12.3.2.1.1. HIV
12.3.2.1.2. Chlamydia
12.3.2.1.3. Others
12.3.2.2. Cancer Predisposition Tests
12.3.2.3. Others
12.3.3. CBC
12.3.4. Chronic Disease Testing
12.3.4.1. Diabetes Testing
12.3.4.2. Hypertension
12.3.4.3. Others
12.3.5. COVID-19 Testing
12.3.6. TSH Testing
12.3.7. Others
12.4. Market Value Forecast, by Provider, 2017–2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Speciality Labs
12.4.4. Diagnostic Centres
13. Spain Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Sample Type, 2017–2031
13.2.1. Blood
13.2.2. Urine
13.2.3. Saliva
13.2.4. Others
13.3. Market Value Forecast, by Test Type, 2017–2031
13.3.1. Genetic Testing
13.3.1.1. Nutrigenetics Test
13.3.1.1.1. Weight Control
13.3.1.1.2. Lactose Intolerance
13.3.1.1.3. Others
13.3.1.2. Celiac Disease Test
13.3.1.3. Sports & Physical Activity Testing
13.3.1.4. Men's Health Tests
13.3.1.5. Women's Health Tests
13.3.1.6. Pregnancy & Prenatal Screening Test
13.3.1.7. General Health Testing
13.3.1.8. Others
13.3.2. Disease Risk Assessment Testing
13.3.2.1. Sexual Health Tests
13.3.2.1.1. HIV
13.3.2.1.2. Chlamydia
13.3.2.1.3. Others
13.3.2.2. Cancer Predisposition Tests
13.3.2.3. Others
13.3.3. CBC
13.3.4. Chronic Disease Testing
13.3.4.1. Diabetes Testing
13.3.4.2. Hypertension
13.3.4.3. Others
13.3.5. COVID-19 Testing
13.3.6. TSH Testing
13.3.7. Others
13.4. Market Value Forecast, by Provider, 2017–2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Speciality Labs
13.4.4. Diagnostic Centres
14. Rest of Europe Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Sample Type, 2017–2031
14.2.1. Blood
14.2.2. Urine
14.2.3. Saliva
14.2.4. Others
14.3. Market Value Forecast, by Test Type, 2017–2031
14.3.1. Genetic Testing
14.3.1.1. Nutrigenetics Test
14.3.1.1.1. Weight Control
14.3.1.1.2. Lactose Intolerance
14.3.1.1.3. Others
14.3.1.2. Celiac Disease Test
14.3.1.3. Sports & Physical Activity Testing
14.3.1.4. Men's Health Tests
14.3.1.5. Women's Health Tests
14.3.1.6. Pregnancy & Prenatal Screening Test
14.3.1.7. General Health Testing
14.3.1.8. Others
14.3.2. Disease Risk Assessment Testing
14.3.2.1. Sexual Health Tests
14.3.2.1.1. HIV
14.3.2.1.2. Chlamydia
14.3.2.1.3. Others
14.3.2.2. Cancer Predisposition Tests
14.3.2.3. Others
14.3.3. CBC
14.3.4. Chronic Disease Testing
14.3.4.1. Diabetes Testing
14.3.4.2. Hypertension
14.3.4.3. Others
14.3.5. COVID-19 Testing
14.3.6. TSH Testing
14.3.7. Others
14.4. Market Value Forecast, by Provider, 2017–2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Speciality Labs
14.4.4. Diagnostic Centres
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. 23andMe, Inc.
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. Ancestry
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. SWOT Analysis
15.2.3. CircleDNA
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. SWOT Analysis
15.2.4. Eurofins Scientific
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.5. Family Tree DNA (Gene by Gene)
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. SWOT Analysis
15.2.6. Laboratory Corporation of America Holdings
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Living DNA Ltd.
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. SWOT Analysis
15.2.8. Medichecks.com Ltd.
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. SWOT Analysis
15.2.9. MyHeritage Ltd.
15.2.9.1. Company Description
15.2.9.2. Business Overview
15.2.9.3. SWOT Analysis
15.2.10. MyMedLab, Inc.
15.2.10.1. Company Description
15.2.10.2. Business Overview
15.2.10.3. SWOT Analysis
15.2.11. Quest Diagnostics Incorporated
15.2.11.1. Company Description
15.2.11.2. Business Overview
15.2.11.3. Financial Overview
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis
List of Tables
Table 01: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 02: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031
Table 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031
Table 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031
Table 07: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031
Table 08: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031
Table 09: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 10: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 11: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031
Table 12: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031
Table 13: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 14: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031
Table 15: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031
Table 16: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031
Table 17: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 18: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 19: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031
Table 20: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031
Table 21: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 22: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031
Table 23: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031
Table 24: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031
Table 25: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 26: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 27: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031
Table 28: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031
Table 29: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 30: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031
Table 31: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031
Table 32: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031
Table 33: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 34: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 35: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031
Table 36: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031
Table 37: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 38: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031
Table 39: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031
Table 40: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031
Table 41: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 42: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 43: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031
Table 44: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031
Table 45: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 46: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031
Table 47: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031
Table 48: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031
Table 49: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 50: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 51: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031
Table 52: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031
Table 53: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 54: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031
Table 55: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031
Table 56: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031
List of Figures
Figure 01: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 02: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031
Figure 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031
Figure 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031
Figure 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031
Figure 07: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 08: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031
Figure 09: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017–2031
Figure 10: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017–2031
Figure 11: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017–2031
Figure 12: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Chronic Disease Testing, 2017–2031
Figure 13: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by COVID-19 Testing, 2017–2031
Figure 14: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017–2031
Figure 15: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031
Figure 16: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 17: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031
Figure 18: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017–2031
Figure 19: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017–2031
Figure 20: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017–2031
Figure 21: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centers, 2017–2031
Figure 22: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031
Figure 23: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 24: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 25: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 26: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031
Figure 27: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 28: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031
Figure 29: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031
Figure 30: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 31: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 32: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 33: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031
Figure 34: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 35: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031
Figure 36: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031
Figure 37: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 38: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 39: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 40: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031
Figure 41: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 42: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031
Figure 43: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031
Figure 44: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 45: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 46: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 47: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031
Figure 48: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 49: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031
Figure 50: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031
Figure 51: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 52: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031
Figure 53: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 54: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031
Figure 55: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 56: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Europe Direct-to-Consumer Laboratory Testing Market Insights, 2021-2031
